NeoGenomics Inc. Common Stock vs Advanced Drainage Systems Inc — how do they compare? NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B), while Advanced Drainage Systems Inc trades at $125.03 (market cap $9.44B). The key difference: Advanced Drainage Systems Inc is far larger — about 4.4× NeoGenomics Inc. Common Stock's market cap, and Advanced Drainage Systems Inc pays a 0.64% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Advanced Drainage Systems Inc for 43 Days on average.
| NEO | WMS | |
|---|---|---|
Market Cap | $2.17B | $9.44B |
Volume | 1,615,943 | 758,325 |
Sector | Health | Basic Materials |
52-Week High | $19.91 | $175.38 |
52-Week Low | $7.19 | $125.19 |
Typical Hold Time | 0 Days | 43 Days |
Enterprise Value | $2.47B | $11.04B |
Dividend Yield | — | 0.64% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WMS (Advanced Drainage Systems) trades at $126.73, up 0.64% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q2 2026 EPS of $2.49, beating estimates, and maintains solid profitability with a 14% net income margin and 24.9% ROE. Recent news includes the release of its 2026 Sustainability Report and a quarterly dividend announcement. Institutional activity is mixed, with BlackRock acquiring a major stake while HighTower Advisors reduced its position.
The outlook for WMS is supported by earnings beats and structural growth in water management solutions, but near-term risks include a projected negative net cash flow for 2026 and competitive pressures. Analyst consensus is a Buy with a $188.20 price target, implying significant upside, though technical indicators suggest caution. Investment appeal hinges on execution of growth initiatives and margin stability amid economic cycles.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →